These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 13508356)

  • 1. Determination of blood levels of para-aminosalicylic acid (PAS) in tuberculous patients treated with various PAS preparations.
    BANG HO; STRANDGAARD E
    Acta Tuberc Scand; 1957; 34(1-2):58-75. PubMed ID: 13508356
    [No Abstract]   [Full Text] [Related]  

  • 2. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
    Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
    Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A micro-method for the determination of paraaminosalicylic acid (aminosallyl) PAS and n-acetyl-para-aminosalicylic acid (acetyl-PAS).
    NIELSEN E; PRAETORIUS E
    Scand J Clin Lab Invest; 1952; 4(4):313-8. PubMed ID: 13048610
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behavior of various serological tests in tuberculotics treated with PAS and PAS plus isoniazid by intravenous perfusions].
    GAIDA A
    Gazz Med Ital; 1956 Nov; 115(11):348-53. PubMed ID: 13384658
    [No Abstract]   [Full Text] [Related]  

  • 5. [The para-aminosalicylic acid (PAS) level of the venous blood in patients after the administration of various PAS preparations for pulmonary tuberculosis].
    Kreukniet J; Tasman A; Bangma PJ
    Ned Tijdschr Geneeskd; 1965 Sep; 109(38):1760-1. PubMed ID: 5317952
    [No Abstract]   [Full Text] [Related]  

  • 6. Para-aminosalicylic-acid (PAS) concentrations in the serum during treatment with various PAS preparations.
    CITRON KM; KUPER SW
    Tubercle; 1959 Dec; 40():443-52. PubMed ID: 13693755
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy of tuberculosis with p-aminosalicylic acid; experimental studies on PAS and sodium-PAS blood level after administration].
    KOELZER PP; WEHR KH; GIESEN J
    Arztl Forsch; 1953 Jul; 7(7):I/336-44. PubMed ID: 13091943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Appearance of goiters in tuberculous treated and cured by PAS; effect of PAS on the thyroid gland of rats].
    COULAUD E
    Rev Tuberc; 1954; 18(3):261-8. PubMed ID: 13205036
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative study of concentrations in the blood of para-aminosalicylic acid in tuberculous patients.
    MOLINARI L; MANRIQUE V
    Dis Chest; 1959 Jul; 36(1):41-2. PubMed ID: 13663726
    [No Abstract]   [Full Text] [Related]  

  • 10. [New method of qualitative & quantitative analysis with para-aminosalicylic acid (PAS) & its calcium, potassium & sodium salts].
    TIMMERMANN E
    Sem Med; 1958 Aug; 113(7):332-3. PubMed ID: 13602901
    [No Abstract]   [Full Text] [Related]  

  • 11. [PAS determination in the blood].
    DUGANDZIC S; DUGANDZIC M
    Arh Farm (Belgr); 1954 Oct; 4(5):161-4. PubMed ID: 14351033
    [No Abstract]   [Full Text] [Related]  

  • 12. [PAS concentration in blood in therapeutic use of PAS and its salts].
    NILSSON H
    Sven Lakartidn; 1952 Apr; 49(16):1044-50. PubMed ID: 14958642
    [No Abstract]   [Full Text] [Related]  

  • 13. [Retarding effect of butazolidine on the elimination of PAS].
    CURCHOD B; CHENET C; VIELHAUER S
    Schweiz Z Tuberk; 1954; 11(3):175-84. PubMed ID: 13205179
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of Para-Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal Intolerance.
    Adams KT; Donald PR; Abulfathi AA; Diacon AH; Stander MA; Reuter H
    J Clin Pharmacol; 2020 Apr; 60(4):489-494. PubMed ID: 31682027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we rely upon the fact that the different PAS-preparations really will be resorbed in the gastrointestinal tract after oral dosage? Some observations during PAS treatment in pulmonary tuberculosis.
    FROSTAD S
    Acta Tuberc Scand; 1960; 39():303-7. PubMed ID: 13702286
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood levels of para-aminosalicylic acid in pulmonary tuberculosis patients treated with various preparations & by various routes of administration. I].
    WARESKA W; LYCZEWSKA J; OSINSKA K
    Gruzlica (1926); 1958 Feb; 26(2):99-112. PubMed ID: 13538325
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic evaluation of para-aminosalicylic acid granules.
    Peloquin CA; Henshaw TL; Huitt GA; Berning SE; Nitta AT; James GT
    Pharmacotherapy; 1994; 14(1):40-6. PubMed ID: 8159600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior of blood and cerebrospinal fluid levels of para-aminosalicylic acid in children affected with meningeal tuberculosis, with special reference to the blood-spinal fluid quotient].
    VIGNOLO-LUTATI U; GAMALERO PC
    Minerva Pediatr; 1953 Apr; 5(7):241-5. PubMed ID: 13072133
    [No Abstract]   [Full Text] [Related]  

  • 19. The concentration of PAS in the blood during medication with PAS or PAS-salts.
    NILSSON H
    Tubercle; 1953 Apr; 34(4):100-4. PubMed ID: 13049572
    [No Abstract]   [Full Text] [Related]  

  • 20. [On PAS calcium salts].
    SMOLAREK W
    Tuberkulosearzt; 1953 May; 7(5):303-5. PubMed ID: 13090340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.